Product Successfully Added

Product name	Pack size	Qty	Price

Add products Proceed to Enquiry

a b c d e f g h i j k l m n o p q r s t u v w x y z

Pharmaceutical Reference Standards / Impurity Standards

Lubiprostone

Lubiprostone

CAT. No.L270000
CAS. No.136790-76-6
Mol. F.C20H32F2O5
Mol. W.390.46 g/mol
Stock Status:Limited Stock

Lubiprostone Related Compound 7

Lubiprostone Related Compound 7

CAT. No.L270004
CAS. No.NA
Mol. F.C20H32F2O5
Mol. W.390.47 g/mol
Stock Status:Custom Synthesis

Lubiprostone impurity 1

Lubiprostone impurity 1

CAT. No.L270005
CAS. No.136790-76-6
Mol. F.C20H32F2O5
Mol. W.390.47g/mol
Stock Status:Limited Stock

7-((1R,2R)-2-(4,4-Difluoro-3-oxooctyl)-5-oxocyclopentyl)heptanoic Acid

7-((1R,2R)-2-(4,4-Difluoro-3-oxooctyl)-5-oxocyclopentyl)heptanoic Acid

CAT. No.L270008
CAS. No.NA
Mol. F.C20H32F2O4
Mol. W.374.46 g/mol
Stock Status:Instock

7-((1R,2R,3R)-2-(4,4-difluoro-3-oxo-1- octyl)-3-(phenylmethoxy)-5-oxo- cyclopentyl)heptanoic Acid

7-((1R,2R,3R)-2-(4,4-difluoro-3-oxo-1- octyl)-3-(phenylmethoxy)-5-oxo- cyclopentyl)heptanoic Acid

CAT. No.L270011
CAS. No.NA
Mol. F.C27H38F2O5
Mol. W.480.58 g/mol
Stock Status:Custom Synthesis

7-((1R,2S)-2-(4,4-difluoro-3-oxo-1-octyl)-5-oxo-3-cyclopentenyl)heptanoic Acid

7-((1R,2S)-2-(4,4-difluoro-3-oxo-1-octyl)-5-oxo-3-cyclopentenyl)heptanoic Acid

CAT. No.L270012
CAS. No.NA
Mol. F.C20H30F2O4
Mol. W.372.45 g/mol
Stock Status:Custom Synthesis

6-(6-Carboxyhexyl)-2-(1,1-difluoropentyl)2,8-dihydroxybicyclo[3.2.1]octan-7-one

6-(6-Carboxyhexyl)-2-(1,1-difluoropentyl)2,8-dihydroxybicyclo[3.2.1]octan-7-one

CAT. No.L270013
CAS. No.NA
Mol. F.C20H32F2O5
Mol. W.390.46 g/mol
Stock Status:Custom Synthesis

1-(6-Carboxyhexyl)-8-(1,1-difluoropentyl)-8-hydroxybicyclo[3.3.0]oct-3-en-2-one

1-(6-Carboxyhexyl)-8-(1,1-difluoropentyl)-8-hydroxybicyclo[3.3.0]oct-3-en-2-one

CAT. No.L270014
CAS. No.NA
Mol. F.C20H30F2O4
Mol. W.372.45 g/mol
Stock Status:Custom Synthesis

3aR,4R,5R,6aS)-2-oxo-5-((tetrahydro-2H-pyran-2-yl)oxy)hexahydro-2H-cyclopenta[b]furan-4-carbaldehyde

3aR,4R,5R,6aS)-2-oxo-5-((tetrahydro-2H-pyran-2-yl)oxy)hexahydro-2H-cyclopenta[b]furan-4-carbaldehyde

CAT. No.L270015
CAS. No.NA
Mol. F.C13H18O5
Mol. W.254.28 g/mol
Stock Status:Custom Synthesis

(3aR,4S,5R,6aS)-4-(hydroxymethyl)-5-((tetrahydro-2H-pyran-2-yl)oxy)hexahydro-2H-cyclopenta[b]furan-2-one

(3aR,4S,5R,6aS)-4-(hydroxymethyl)-5-((tetrahydro-2H-pyran-2-yl)oxy)hexahydro-2H-cyclopenta[b]furan-2-one

CAT. No.L270016
CAS. No.NA
Mol. F.C13H20O5
Mol. W.256.29 g/mol
Stock Status:Custom Synthesis

((+/-)-Corey Lactone Diol

((+/-)-Corey Lactone Diol

CAT. No.L270017
CAS. No.54423-47-1
Mol. F.C8H12O4
Mol. W.172.18 g/mol
Stock Status:Custom Synthesis

Lubiprostone Impurity 1

Lubiprostone Impurity 1

CAT. No.L270018
CAS. No.NA
Mol. F.C20H32F2O5
Mol. W.390.46 g/mol
Stock Status:Custom Synthesis

Lubiprostone Impurity ll

Lubiprostone Impurity ll

CAT. No.L270019
CAS. No.NA
Mol. F.C20H32F2O5
Mol. W.390.46 g/mol
Stock Status:Custom Synthesis

Lubiprostone Hemiketal

Lubiprostone Hemiketal

CAT. No.L270021
CAS. No.333963-40-9
Mol. F.C20H32F2O5
Mol. W.390.46 g/mol
Stock Status:Custom Synthesis

5-Amino Lenalidomide

5-Amino Lenalidomide

CAT. No.L270022
CAS. No.191732-74-8
Mol. F.C13H13N3O3
Mol. W.259.26 g/mol
Stock Status:Custom Synthesis

7-((1R,2R,3R)-2-(4,4-difluoro-3-oxooctyl)-5-oxo-3-((tetrahydro-2H-pyran-2-yl)oxy)cyclopentyl)heptanoic acid

7-((1R,2R,3R)-2-(4,4-difluoro-3-oxooctyl)-5-oxo-3-((tetrahydro-2H-pyran-2-yl)oxy)cyclopentyl)heptanoic acid

CAT. No.L270023
CAS. No.NA
Mol. F.C25H40F2O6
Mol. W.474.58 g/mol
Stock Status:Custom Synthesis

cyclohexylmethyl 7-((2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yl)heptanoate

cyclohexylmethyl 7-((2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yl)heptanoate

CAT. No.L270024
CAS. No.NA
Mol. F.C27H44F2O5
Mol. W.486.63 g/mol
Stock Status:Custom Synthesis

(Z)-benzyl 7-((2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yl)hept-5-enoate

(Z)-benzyl 7-((2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yl)hept-5-enoate

CAT. No.L270025
CAS. No.NA
Mol. F.C27H36F2O5
Mol. W.478.57 g/mol
Stock Status:Custom Synthesis

7-(2-(4,4-difluoro-3-oxooctyl)-5-oxocyclopent-3-en-1-yl)heptanamide (RS)

7-(2-(4,4-difluoro-3-oxooctyl)-5-oxocyclopent-3-en-1-yl)heptanamide (RS)

CAT. No.L270026
CAS. No.NA
Mol. F.C20H31F2NO3
Mol. W.371.46 g/mol
Stock Status:Custom Synthesis

Metabolites

15-Hydroxy Lubiprostone

15-Hydroxy Lubiprostone

CAT. No.L270001
CAS. No.47592-30-4
Mol. F.C20H34F2O5
Mol. W.392.48 g/mol
Stock Status:Please Enquire

Isotope Labelled Compounds

Lubiprostone D7

Lubiprostone D7

CAT. No.L270002
CAS. No.1217675-13-2
Mol. F.C20H25D7F2O5
Mol. W.397.51 g/mol
Stock Status:Please Enquire

15-Hydroxy Lubiprostone-d4

15-Hydroxy Lubiprostone-d4

CAT. No.L270003
CAS. No.NA
Mol. F.C20H30D4F2O5
Mol. W.396.51 g/mol
Stock Status:Please Enquire

15-Hydroxy Lubiprostone-D7

15-Hydroxy Lubiprostone-D7

CAT. No.L270020
CAS. No.475992-30-4(non-labelled)
Mol. F.C20H27D7F2O5
Mol. W.399.52 g/mol
Stock Status:Please Enquire